ECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addicts

Pani PP, Trogu E, Maremmani I, Amato L, Minozzi S, Vecchi S, Davoli M

Published Online:

January 19, 2011

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary aim of the review is the risk-benefit evaluation of electrocardiograph screening for preventing morbidity and mortality associated with methadone-related QTc interval prolongation in opioid addicts.

Abstract (click to read)

This record should be cited as:

Pani PP, Trogu E, Maremmani I, Amato L, Minozzi S, Vecchi S, Davoli M. ECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addicts. Cochrane Database of Systematic Reviews 2011, Issue 1. Art. No.: CD008939. DOI: 10.1002/14651858.CD008939

Find the research

Get full text at The Cochrane Library

Primary Review Group:

Drugs and Alcohol Group

Cochrane Summaries^beta

Independent high-quality evidence for health care decision making

ECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addicts

More like this

Copyright © 2012 - The Cochrane Collaboration